| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 501 | 2016 |
| 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales JH Kuhn, S Adkins, D Alioto, SV Alkhovsky, GK Amarasinghe, SJ Anthony, ... Archives of virology 165 (12), 3023-3072, 2020 | 325 | 2020 |
| Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis P Aleksandrowicz, A Marzi, N Biedenkopf, N Beimforde, S Becker, ... The Journal of infectious diseases 204 (suppl_3), S957-S967, 2011 | 308 | 2011 |
| A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA K Ewer, T Rampling, N Venkatraman, G Bowyer, D Wright, T Lambe, ... New England Journal of Medicine 374 (17), 1635-1646, 2016 | 298 | 2016 |
| Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription T Hoenen, N Biedenkopf, F Zielecki, S Jung, A Groseth, H Feldmann, ... Journal of virology 84 (14), 7053-7063, 2010 | 135 | 2010 |
| Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication N Biedenkopf, B Hartlieb, T Hoenen, S Becker Journal of Biological Chemistry 288 (16), 11165-11174, 2013 | 123 | 2013 |
| Role of Ebola virus VP30 in transcription reinitiation MJ Martinez, N Biedenkopf, V Volchkova, B Hartlieb, N Alazard-Dany, ... Journal of virology 82 (24), 12569-12573, 2008 | 113 | 2008 |
| The natural compound silvestrol is a potent inhibitor of Ebola virus replication N Biedenkopf, K Lange-Grünweller, FW Schulte, A Weißer, C Müller, ... Antiviral research 137, 76-81, 2017 | 105 | 2017 |
| The Ebola virus nucleoprotein recruits the host PP2A-B56 phosphatase to activate transcriptional support activity of VP30 T Kruse, N Biedenkopf, EPT Hertz, E Dietzel, G Stalmann, ... Molecular cell 69 (1), 136-145. e6, 2018 | 85 | 2018 |
| Dose-dependent T-cell dynamics and cytokine cascade following rVSV-ZEBOV immunization C Dahlke, R Kasonta, S Lunemann, V Krähling, ME Zinser, N Biedenkopf, ... EBioMedicine 19, 107-118, 2017 | 80 | 2017 |
| Transport of Ebolavirus nucleocapsids is dependent on actin polymerization: live-cell imaging analysis of Ebolavirus-infected cells G Schudt, O Dolnik, L Kolesnikova, N Biedenkopf, A Herwig, S Becker The Journal of infectious diseases 212 (suppl_2), S160-S166, 2015 | 75 | 2015 |
| Dynamic phosphorylation of VP30 is essential for Ebola virus life cycle N Biedenkopf, C Lier, S Becker Journal of virology 90 (10), 4914-4925, 2016 | 73 | 2016 |
| Analysis of Ebola virus entry into macrophages F Dahlmann, N Biedenkopf, A Babler, W Jahnen-Dechent, CB Karsten, ... The Journal of infectious diseases 212 (suppl_2), S247-S257, 2015 | 72 | 2015 |
| Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry L Henß, S Beck, T Weidner, N Biedenkopf, K Sliva, C Weber, S Becker, ... Virology journal 13, 1-8, 2016 | 71 | 2016 |
| Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: a phase I randomised trial ST Agnandji, JF Fernandes, EB Bache, RM Obiang Mba, JS Brosnahan, ... PLoS medicine 14 (10), e1002402, 2017 | 67 | 2017 |
| From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein F Hempel, M Maurer, B Brockmann, C Mayer, N Biedenkopf, ... Microbial cell factories 16, 1-10, 2017 | 58 | 2017 |
| RNA binding of Ebola virus VP30 is essential for activating viral transcription N Biedenkopf, J Schlereth, A Grünweller, S Becker, RK Hartmann Journal of virology 90 (16), 7481-7496, 2016 | 58 | 2016 |
| Detectable Vesicular Stomatitis Virus (VSV)–specific humoral and cellular immune responses following VSV–Ebola virus vaccination in humans JH Poetsch, C Dahlke, ME Zinser, R Kasonta, S Lunemann, A Rechtien, ... The Journal of infectious diseases 219 (4), 556-561, 2019 | 39 | 2019 |
| New perspectives on the biogenesis of viral inclusion bodies in negative-sense RNA virus infections O Dolnik, GK Gerresheim, N Biedenkopf Cells 10 (6), 1460, 2021 | 35 | 2021 |
| RNA binding specificity of Ebola virus transcription factor VP30 J Schlereth, A Grünweller, N Biedenkopf, S Becker, RK Hartmann RNA biology 13 (9), 783-798, 2016 | 35 | 2016 |
